Paxil Authorized Generic: Par Gets Puerto Rico Now, States Later
Executive Summary
Par and Pentech will be entitled to launch an "authorized" generic version of GlaxoSmithKline's Paxil on U.S. mainland once another generic is launched, under the companies' patent litigation settlement
You may also be interested in...
GSK/Par Paxil Generic Deal Upheld In Court; FTC Closes Patent Investigation
GlaxoSmithKline's "authorized" generic Paxil agreement with Par does not raise any antitrust concerns, Chicago federal court Judge Richard Posner ruled Oct. 29
GSK/Par Paxil Generic Deal Upheld In Court; FTC Closes Patent Investigation
GlaxoSmithKline's "authorized" generic Paxil agreement with Par does not raise any antitrust concerns, Chicago federal court Judge Richard Posner ruled Oct. 29
Apotex Generic Paxil Priced At 7% Discount Following “At Risk” Launch
Apotex is relying on a district court ruling of noninfringement in launching the first generic of GlaxoSmithKline's antidepressant Paxil (paroxetine)